SEARCH

SEARCH BY CITATION

References

  • Angelico M, Renganathan E, Gandin C et al. (1997) Chronic liver disease in the Alexandria governorate: Egypt: contribution of schistosomiasis and hepatitis virus infections. Journal of Hepatology 26, 236243.
  • Anonymous (1997) Centers for Disease Control and Prevention. Recommendations for follow-up of health care workers after occupational exposure to hepatitis C virus. Morbidity and Mortality Weekly Report 46, 603606.
  • Darwish MA, Raouf TA, Rushdy P et al. (1993) Risk factors associate with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. American Journal of Tropical Medicine and Hygiene 49, 440447.
  • El-Sayed NM, Gomatos PJ, Rodier GR et al. (1996) Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt. American Journal of Tropical Medicine and Hygiene 55, 179184.
  • El-Zayadi AR, Abe K, Selim O et al. (1999) Prevalence of GBV-C/hepatitis G virus viraemia among blood donors, health care personnel, chronic non-B non-C hepatitis, chronic hepatitis C and hemodialysis patients in Egypt. Journal of Virology Methods 80, 5358.
  • Frank C, Mohamed MK, Strickland GT et al. (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 11, 887891.
  • Gumodoka B et al. (1996) Injection practices in Mwanza Region, Tanzania: prescriptions, patient demand and sterility. Tropical Medicine and International Health 1, 884880.
  • Habib M, Mohamed MK, Abdel-Aziz F et al. (2001) Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 33, 248253.
  • Hersh BS, Popovici F, Apetrei RC et al. (1991) Acquired immunodeficiency syndrome in Romania. Lancet 338, 645649.
  • Hutin YJ, Harpaz R, Drobeniuc J et al. (1999) Injections given in healthcare settings as a major source of acute hepatitis B in Moldova. International Journal of Epidemiology 28, 782786.
  • Hyams KC, Mansour MM, Massoud A et al. (1987) Parenteral antischistosomal therapy: a potential risk factor for hepatitis B infection. Journal of Medicine and Virology 23, 09114.
  • Luby SP, Qamruddin K, Shah AA et al. (1997) The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiology and Infection 119, 349356.
  • Mohamed MK et al. (1996) Viral hepatitis C infection among Egyptians. The magnitude of the problem: epidemiological and laboratory approach. Journal of Egyptian Public Health Association 71, 80111.
  • Raglow G, Luby S & Nabi N (2001) Therapeutic injections in Pakistan: from the patients' perspective. Tropical Medicine and International Health 6, 6975.
  • Reeler AV & Hematorn C (1994) Injection Practices in the Third World. A Case Study of Thailand. Geneva: World Health Organization (WHO/DAP/94.8).
  • Singh J, Bhatia R, Gandhi JC et al. (1998) Outbreak of viral hepatitis B in a rural community in India linked to inadequately sterilized needles and syringes. Bulletin of the World Health Organization 76, 9398.
  • Sullivan K, Kalsbeek W, Chen M et al. (1994) Csample: Analyzing Data from Complex Survey Samples. EPI-Info, Version 6. Atlanta: Centers for Disease Control and Prevention, pp. 157184.
  • Tibbs CJ (1997) Tropical aspects of viral hepatitis. Hepatitis C. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 121124.
  • Van Staa AL & Hardon A (1996) Injection Practices in the Developing World: a Comparative Review of Field Studies in Uganda and Indonesia. Geneva: World Health Organization (WHO/DAP/96.4).
  • Vos J, Gumodoka B, Can Asten HA, Berege ZA et al. (1998) Improved injection practices after the introduction of treatment and sterility guidelines in Tanzania. Tropical Medicine and International Health 3, 291292.